Home Mural Oncology

Mural Oncology

In operation
IPO
Immunotherapy Developer
Basic
Enterprise Profile

Basic Information

Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapy for cancer treatment. Our expertise in cytokine biology and immune cell modulation, combined with our unparalleled protein engineering capabilities, will enable us to develop drugs that deliver meaningful and clinical benefits to cancer patients. Our mission is to expand the potential and scope of cytokine-based immunotherapies to improve patients' lives.
Mural Oncology Plc
Massachusetts,United States of America
unclear
--
ir@muraloncology.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Immunological Techniques
Concept
Tumor
Application Scenarios
Innovative Drugs